Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean ME, et al
Research has shown that GLP-1 receptor agonists can be incredibly effective in reversing this trend
They have studied abroad and have a greater trust in foreign products
Henkin, R
If you are at risk of developing diabetes, high blood pressure, heart disease, all these things that obesity can contribute to, then I would argue that its not a good thing, but its not about shaming. Public health approach Sceppa stresses that while GLP-1 medications can drive weight loss, they also come with trade-offs
Individual metabolic variation : Factors such as baseline insulin resistance, gut hormone sensitivity, and adherence to the injection schedule all play a role